University of California, San Francisco
This is a single-arm hybrid implementation trial of men with metastatic castrate-resistant prostate cancer (mCRPC) involving a patient-administered mobile app for consultation audio recordings.
Prostate Cancer
Metastatic Prostate Cancer
Metastatic Castration-resistant Prostate Cancer
Consultation audio recording app
Not Applicable
PRIMARY OBJECTIVE: 1. To evaluate change in participant informed decision-making after provision of a consultation audio recording application. SECONDARY OBJECTIVES: Reach. To evaluate the percentage of invited participants who enroll. Reasons for not enrolling will be assessed. Adoption. To evaluate the percentage of providers who agree to be recorded. Adoption. To evaluate the percentage of participants who create an audio recording. Adoption. To evaluate the percentage of participants who listen to the audio recording or read its automatically generated transcript. Implementation. To evaluate the percentage of participants who report receiving instructions on how to record. To evaluate participant-reported shared decision-making effort. To evaluate whether participant-reported anxiety changes after provision of a consultation audio recording app. To evaluate barriers, facilitators, and experiences of recording app use, particularly in the context of treatment decision-making by conducting participant interviews, provider surveys, and interviews with providers. Treatment received. EXPLORATORY OBJECTIVES: To evaluate whether provision of a consultation audio recording app improves participant-reported knowledge retention of docetaxel. To evaluate accuracy of app auto-generated transcription. To evaluate degree of provider decision support and communication skills. Participants are set up with an application prior to the first physician visit and then followed-up 7 days, 28 days and 60 days after their physician encounter.
Study Type : | Interventional |
Estimated Enrollment : | 51 participants |
Masking: | None (Open Label) |
Primary Purpose: | Health Services Research |
Official Title: | Mhealth ElectroNic COnsultation REcording (MENCORE-2): an Implementation Trial to Improve Informed Treatment Decision-making in Men With Advanced Prostate Cancer |
Actual Study Start Date : | March 22, 2022 |
Estimated Primary Completion Date : | February 18, 2024 |
Estimated Study Completion Date : | April 30, 2024 |
Arm | Intervention/treatment |
---|---|
Experimental: Consultation audio recording Instructions on installation and detailed use of chosen application will be provided before an upcoming oncology visit. Research staff will contact the participant and encourage a "practice" recording session. 15-30 minutes prior to the consultation, research staff will send an anonymous text message to the participants' mobile device with a reminder to record the visit. Three days after the consultation, research staff will send an anonymous text reminder message to the participants' mobile device to listen to the recording. |
Behavioral: Consultation audio recording app |
Ages Eligible for Study: | 18 Years |
Sexes Eligible for Study: | Male |
Accepts Healthy Volunteers: | No |
Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.
Not yet recruiting
University of California, San Francisco
San Francisco, California, United States, 94143